LASIK increases night-time halos

Article

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Cesar Villa Collar from the Clinica Oftalmologica Novovision, Spain and colleagues conducted a prospective, observational, analytical study to evaluate the changes in correlations of higher order aberrations (HOAs) of the first corneal surface with halo phenomena under night vision conditions. A total of 11 eyes that had undergone successful LASIK for myopia and astigmatism were examined. Preoperative sphere was -3.48±1.70 D and preoperative cylinder was -0.86±0.87 D. Visual disturbances and pupil size were measured after adaptation to a dark environment.

The halo disturbance index increased by a factor of 2.15 after successful LASIK surgery and total RMS for monochromatic HOA displayed a significant correlation with the halo disturbance index (r=0.36; p<0.01). However, only secondary astigmatism (r=0.36; p<0.01), coma (r=0.25; p=0.02) and spherical aberration (r=0.40; p<0.01) were responsible for this behaviour, with the remaining corneal aberrations until the 6th order not displaying any significant correlation.

It was concluded that LASIK can cause an increase in halos even when the results of the surgery are considered entirely satisfactory according to current international standards of predictability, efficacy and safety.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.